Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours Β· Estimated delivery Oct 11 - Oct 16
GHK-Cu published research history: - First isolated and characterized: 1973 - Continuous peer-reviewed publication: 50+ years - Published research covering: wound healing, skin biology, COPD, oxidative stress, bone, skeletal muscle, gastrointestinal, neurological, gene expression, aging - Mechanistic characterization: Multiple pathways identified, SIRT1 direct binding confirmed in 2025 - Cell and animal model validation: Extensive across multiple tissue types and species Matrixyl 3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) research: - Commercial introduction: Early 2000s - Research base: Primarily cosmetic science and dermatology literature - Mechanistic characterization: Primarily focused on TGF-beta receptor and IL-6 pathways - Depth: Narrower tissue focus, smaller body of published mechanistic research For researchers who need a compound with extensive published mechanistic context, detailed gene expression data, or research across multiple tissue types, GHK-Cu's research depth is substantially greater
Each is supplied separately and not co-formulated
The group first came to our attention a year ago, when they lost two papers in PLOS ONE
Think of it this way
Did you know that pairing B12 shots with Botox treatments can enhance overall results by helping you feel more vibrant and confident, complementing the aesthetic benefits
US$ 24.60
US$ 27.89
US$ 26.08
